News headlines about National Health Investors (NYSE:NHI) have been trending somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. National Health Investors earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned media headlines about the real estate investment trust an impact score of 45.6648084176988 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

NHI stock opened at $77.41 on Friday. The company has a quick ratio of 15.56, a current ratio of 15.56 and a debt-to-equity ratio of 0.90. The stock has a market cap of $3.32 billion, a price-to-earnings ratio of 14.52, a P/E/G ratio of 3.40 and a beta of 0.35. National Health Investors has a twelve month low of $62.71 and a twelve month high of $81.60.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Tuesday, August 7th. The real estate investment trust reported $0.91 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.96 by ($0.05). The business had revenue of $72.96 million for the quarter, compared to the consensus estimate of $73.80 million. National Health Investors had a net margin of 53.16% and a return on equity of 11.49%. sell-side analysts expect that National Health Investors will post 5.51 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 9th. Stockholders of record on Friday, September 28th will be given a dividend of $1.00 per share. The ex-dividend date is Thursday, September 27th. This represents a $4.00 dividend on an annualized basis and a dividend yield of 5.17%. National Health Investors’s dividend payout ratio (DPR) is presently 75.05%.

A number of research analysts have weighed in on the company. Wells Fargo & Co reaffirmed a “hold” rating on shares of National Health Investors in a report on Tuesday, August 28th. Capital One Financial raised National Health Investors from an “equal weight” rating to an “overweight” rating in a report on Friday, May 11th. SunTrust Banks reaffirmed a “hold” rating and set a $79.00 target price on shares of National Health Investors in a report on Wednesday, August 8th. They noted that the move was a valuation call. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of National Health Investors in a report on Wednesday, May 16th. Finally, Stifel Nicolaus set a $83.00 target price on National Health Investors and gave the company a “buy” rating in a report on Tuesday, August 7th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company. National Health Investors presently has a consensus rating of “Hold” and a consensus target price of $75.44.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Further Reading: Dividend Stocks – Are They Right For You?

Insider Buying and Selling by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with's FREE daily email newsletter.